Matches in DBpedia 2015-10 for { ?s ?p "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354 and taken through pre-clinical development. As of April 2012 it is being developed by MedImmune, a member of the AstraZeneca group, where it is currently in Ph3 testing for asthma and Ph2 testing for atopic dermatitis."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Tralokinumab comment "Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.Tralokinumab was discovered by Cambridge Antibody Technology scientists, using Ribosome Display, as CAT-354 and taken through pre-clinical development. As of April 2012 it is being developed by MedImmune, a member of the AstraZeneca group, where it is currently in Ph3 testing for asthma and Ph2 testing for atopic dermatitis.".